Evofem Biosciences, Inc. (EVFM) is a publicly traded company in the Unknown sector. Across all available filings, 15 corporate insiders have executed 153 transactions totaling $87.7M, demonstrating a bullish sentiment with $22.1M in net insider flow. The most recent transaction on Jan 12, 2024 involved a sale of 104 shares valued at $4.
No significant insider buying has been recorded for EVFM in the recent period.
No significant insider selling has been recorded for EVFM in the recent period.
Based on recent SEC filings, insider sentiment for EVFM is bullish with an Insider Alignment Score of 63/100 and a net flow of $22.1M. Insiders are accumulating shares, which historically signals confidence in the company's future performance.
Insider trading at Evofem Biosciences, Inc. (EVFM) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 15 insiders are actively trading EVFM stock, having executed 153 transactions in the past 90 days. The most active insider is Biopharma, Inc. Pdl (Executive), who has made 2 transactions totaling $30.0M.
Get notified when executives and directors at EVFM file new Form 4 transactions
Date | Insider | Title | Type | Shares | Price | Value | Flags |
|---|---|---|---|---|---|---|---|
| Jan 12, 2024 | Zhang Yan | Executive | Sale | 104 | $0.04 | $4 | |
| Dec 21, 2023 | P. Kamdar Kim | Executive | Sale | 10 | $0.62 | $6 | |
| Dec 31, 2022 | L. Pelletier Saundra | Executive | Disposition | 50,000 | $N/A | $0 | |
| Dec 31, 2022 | J. File Justin | Executive | Disposition | 30,000 | $N/A | $0 | |
| May 27, 2022 | L. Pelletier Saundra | Executive | Purchase | 141,000 | $0.35 | $49.4K | |
| Feb 18, 2022 | L. Pelletier Saundra | Executive | Award | 750,000 | $N/A | $0 | |
| Feb 18, 2022 | J. File Justin | Executive | Award | 450,000 | $N/A | $0 | |
| Feb 18, 2022 | A. Fitzpatrick Alexander | Executive | Award | 300,000 | $N/A | $0 | |
| Dec 31, 2021 | L. Pelletier Saundra | Executive | Disposition | 300,000 | $N/A | $0 | |
| Dec 31, 2021 | J. File Justin | Executive | Disposition | 120,000 | $N/A | $0 | |
| Dec 31, 2021 | A. Fitzpatrick Alexander | Executive | Disposition | 120,000 | $N/A | $0 | |
| Dec 20, 2021 | L. Pelletier Saundra | Executive | Purchase | 135,000 | $0.38 | $51.3K | |
| Dec 20, 2021 | J. File Justin | Executive | Purchase | 40,594 | $0.37 | $15.0K | |
| Dec 20, 2021 | A. Fitzpatrick Alexander | Executive | Purchase | 25,000 | $0.39 | $9.8K | |
| Jul 8, 2021 | Barrans Russell | Executive | Payment | 19,998 | $0.98 | $19.6K |
| TYPE | COUNT | VALUE | % |
|---|---|---|---|
Purchase(P) | 34 | $54.9M | 58.7% |
Sale(S) | 24 | $32.8M | 35.1% |
Payment(F) | 54 | $5.3M | 5.6% |
Other(J) | 3 | $400.2K | 0.4% |
Award(A) | 28 | $64.0K | 0.1% |
Disposition(D) | 5 | $0 | 0.0% |
Exercise(M) | 5 | $0 | 0.0% |
Insiders at Evofem Biosciences, Inc. are accumulating shares at an accelerated pace. With 15 insiders making 153 transactions totaling $54.9M in purchases versus $32.8M in sales, the net buying activity of $22.1M signals strong executive confidence. Biopharma, Inc. Pdl (Executive) leads the buying activity with $30.0M in transactions across all time.